Aigerim Adekenova

Dr. Aigerim Adekenova

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2025 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
AKAnarkul S. Kishkentayeva
Anarkul S. Kishkentayeva
MHMohammad Saleh Hamad
Mohammad Saleh Hamad
MPMikhail Andreevich Pokrovsky
Mikhail Andreevich Pokrovsky
ZSZhanar Shaimerdenova
Zhanar Shaimerdenova
AAAigerim Adekenova
Aigerim Adekenova
Elvira ShultsElvira Shults
Elvira Shults
Despite the discovery of many chemotherapeutic drugs that prevent uncontrolled cell division processes, the development of compounds with higher anticancer efficacy and a lower level of side effects is an important task in modern pharmaceutical chemistry. Herein, a mild and convenient method for the preparation of N1-substituted 3-(1,2,3-triazolyl-methoxycarbonyl)coumarins or bis(coumarine-3-carboxylate)bis(triazole)alkandiyl by the copper(I)-catalyzed Huisgen cycloaddition reaction of readily available coumarin-3-carboxylic acid propynyl ester with azides or diazides has been presented. The synthesized compounds have been tested for their cytotoxicity on various cancer and noncancerous cell lines using the MTT assay. All new compounds were nontoxic on normal epithelial VERO cells. Two derivatives exhibited selectivity towards HPV-negative human cervical cancer cells, C33 A, with excellent activities in low concentrations (GI50 4.4–7.0 µM). In vitro mechanistic studies showed that bis(coumarine)bis(triazolylester) conjugate 3 induced time-dependent apoptosis in cervical cancer cell lines C33 A and CaSki, at the GI50 concentration, as measured by Annexin V-FITC/PI staining. The most active coumarin–triazolyl ester conjugate 2g possessed anticancer activities, as indicated by its ability to induce S/G2 phase cell cycle arrest at a low concentration and early apoptosis in CaSki cells. The obtained results revealed the potential of new compounds as anticancer agents, particularly against cervical cancer.

30 April 2024 in Chromatographia
Verified
Journal Article
Closed access
PDF file
SASergazy Adekenov
Sergazy Adekenov
ZSZhanar Shaimerdenova
Zhanar Shaimerdenova
DNDarkhan Kairatuly Nurkadirov
Darkhan Kairatuly Nurkadirov
AAAigerim Adekenova
Aigerim Adekenova
Alain BerthodAlain Berthod
Alain Berthod

20 October 2025 in Molecules
Verified
Journal Article
Open access
PDF file
KKKymbat Kopbalina
Kymbat Kopbalina
AAAigerim Adekenova
Aigerim Adekenova
ZSZhanar Shaimerdenova
Zhanar Shaimerdenova
ZKZhanargul Kairatova
Zhanargul Kairatova
KSKuanysh Shakarimova
Kuanysh Shakarimova
RJRoza Jalmakhanbetova
Roza Jalmakhanbetova
Cytisine and coumarin derivatives are promising for the creation of new drugs with antiarrhythmic, antiepileptic, antidiabetic, anti-inflammatory, and antimicrobial effects. In this study, the molecular structure of the cytisine and coumarin derivative in solution, a recently synthesized substance N-(2-oxo-2H-chromen-3-carbonyl)cytisine, was studied by NMR and UV-Vis absorption spectroscopies accompanied by a theoretical study based on density functional theory. The existence of four stable conformers associated with the rotation of the cytisine part relative to the coumarin part due to a sufficiently flexible intermediate part has been demonstrated. Their energy and concentrations were estimated. In the 1H and 13C NMR spectra, peaks were found that correspond to individual conformers and groups of conformers. The UV-visible absorption spectrum also revealed spectral features associated with different conformers. It was shown that the obtained results are consistent with earlier studies about conformational state identification in cytisine derivatives functionalized with flexible parts. The obtained theoretical and experimental results provide useful spectroscopic information for such conformer identification in this and structurally similar substances.